Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Interference01:23

RNA Interference

29.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
29.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Gene Therapy00:59

Gene Therapy

28.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.3K
Gene Therapy00:59

Gene Therapy

4.9K
4.9K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

1.3K
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated targeted whole-genome and RNA-sequencing analysis of an intronic GNE variant in GNE myopathy.

Human genome variation·2026
Same author

Nationwide screening identifies an expanded clinical spectrum of anti-KLHL11 antibody-associated neurologic disease in Japan.

Journal of neurology·2026
Same author

[Acute Measles Encephalitis].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same author

Guanine base modifications in antisense oligonucleotides mitigate acute central nervous system toxicity.

RSC chemical biology·2026
Same author

n-Hexane-Toxic Neuropathy Presenting with Cauda Equina Inflammation.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

Anti-NXP2 antibody-positive dermatomyositis presenting as systemic capillary leak syndrome with cutaneous and gastrointestinal ulcers.

Rheumatology advances in practice·2026

Related Experiment Video

Updated: Apr 18, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

54.2K

Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol.

Tomoko Nishina1, Junna Numata2, Kazutaka Nishina1

  • 11] Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan [2] Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan.

Molecular Therapy. Nucleic Acids
|January 14, 2015
PubMed
Summary

Researchers developed a novel drug delivery system using α-tocopherol-conjugated chimeric antisense oligonucleotides (ASOs) for enhanced liver gene silencing. This new structure improves ASO delivery and efficacy in vivo.

More Related Videos

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.7K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

54.2K
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.7K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.4K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Delivery Systems

Background:

  • Short interfering RNA (siRNA) conjugated with α-tocopherol shows efficient liver delivery and gene silencing.
  • Direct α-tocopherol conjugation to locked nucleic acid (LNA)-DNA gapmer antisense oligonucleotides (ASOs) reduced in vivo silencing activity.

Purpose of the Study:

  • To enhance the delivery and efficacy of ASOs in the liver.
  • To develop a novel ASO structure for improved gene silencing.

Main Methods:

  • Conjugation of α-tocopherol to unlocked nucleic acid (UNA) sequences as a "second wing" to LNA-DNA gapmer ASOs.
  • Intravenous injection of chimeric ASOs into mice.
  • Assessment of gene silencing activity and hepatic tropism in vivo.

Main Results:

  • The α-tocopherol-conjugated chimeric ASO demonstrated more potent liver gene silencing compared to ASO alone.
  • The UNA wing was cleaved intracellularly, releasing α-tocopherol and activating the ASO.
  • The novel ASO structure exhibited high efficacy, hepatic tropism, and safety for in vivo gene silencing.

Conclusions:

  • A new, effective LNA-DNA gapmer structure was identified, utilizing drug delivery system (DDS) molecules bound to ASOs via UNA sequences.
  • This approach significantly improves ASO delivery and gene silencing efficacy in the liver.
  • The developed chimeric ASO is a promising tool for in vivo gene silencing applications.